Question 1

Has Shashi Patel received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $3,325 in general payments to Shashi Patel across 106 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Shashi Patel did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Shashi Patel come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
GSK	30	$1,007
AstraZeneca	10	$610
Insmed, Inc.	11	$288
Boehringer Ingelheim	11	$237
Abbott	1	$175
Pfizer	2	$141
Vyaire Medical, Inc.	2	$125
Circassia Inc.	5	$94
Electromed, Inc.	5	$69
Regeneron Healthcare Solutions, Inc.	3	$62
Actelion Pharmaceuticals US, Inc.	2	$61
Mylan Specialty L.p.	3	$57
Philips North America LLC	3	$52
AbbVie	2	$48
Jazz Pharmaceuticals Inc.	2	$44
Sunovion Pharmaceuticals Inc.	2	$42
Optinose US, Inc.	2	$40
Teva Pharmaceuticals USA, Inc.	2	$39
Advanced Respiratory, Inc	2	$34
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$33
Merck	2	$31
Novo Nordisk	1	$18
Pacira Pharmaceuticals Incorporated	1	$17

Shashi Patel

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other pulmonary disease in Far Rockaway